• 1
    Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 673540.
  • 2
    Stemmermann GN. Intestinal metaplasia of the stomach. Cancer 1994; 74: 55664.
  • 3
    Jass JR, Filipe MI. Sulphomucins and precancerous lesions of the human stomach. Histopathology 1980; 4: 2719.
  • 4
    Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, pre-neoplastic and neoplastic human gastric epithelium. Cancer Res 1995; 55: 268190.
  • 5
    Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC and MUC6) expression. Cancer Res 1999; 59: 10037.
  • 6
    Matsukura N, Suzuki K, Kawachi T, et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst 1980; 65(2): 23140.
  • 7
    Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 3249.
  • 8
    You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999; 83(5): 6159.
  • 9
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 10
    Genta RM, Rugge M. Review article: pre-neoplastic states of the gastric mucosa—a practical approach for the perplexed clinician. Aliment Pharmacol Ther 2001; 15(Suppl. 1): 4350.
  • 11
    Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000; 95: 14318.
    Direct Link:
  • 12
    Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 24.
  • 13
    Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. NEngl J Med 1996; 335: 2429.
  • 14
    Tsukui T, Kashiwagi R, Sakane M, et al. Aging increase and duodenal ulcer reduce the risk of intestinal metaplasia of the gastric corpus in Japanese patients with dyspepsia. J Gastroenterol Hepatol 2001; 16: 1521.
  • 15
    El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398402.DOI: 10.1038/35006081
  • 16
    Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2(7924): 5860.
  • 17
    De Koster E, Buset M, Fernandes E, et al. Helicobacter pylori: thelink with gastric cancer. Eur J Cancer Prev 1994; 3: 24757.
  • 18
    Fox JG, Dangler CA, Taylor NS, et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999; 59: 48238.
  • 19
    Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158: 64754.
  • 20
    Prinz C, Schoniger M, Rad R, et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001; 61: 1903–9.
  • 21
    Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498501.
  • 22
    Peek RM, Moss SF, Tham KT, et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 8638.
  • 23
    Leung WK, To KF, Chan FKL, Lee TL, Chung SCS, Sung JJY. Interaction of H. pylori and NSAID on gastric epithelial cell apoptosis and proliferation: implications on ulcerogenesis. Aliment Pharmacol Ther 2000; 14: 87985.
  • 24
    Leung WK, Yu J, To KF, et al. Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia. Aliment Pharmacol Ther 2001; 15: 146772.
  • 25
    Shiao YH, Rugge M, Correa P, et al. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 5117.
  • 26
    Wu MS, Shun CT, Lee WC, et al. Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer. Br J Cancer 1998; 78: 9713.
  • 27
    Dubois RN. Review article: cyclooxygenase—a target for colon cancer prevention. Aliment Pharmacol Ther 2000; 14(Suppl. 1): 647.
  • 28
    Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 1995; 83: 493501.
  • 29
    Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 333640.
  • 30
    Chan FK, To KF, Ng YP, et al. Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment Pharmacol Ther 2001; 15: 18793.
  • 31
    Sung JJY, Leung WK, Go MYY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000; 157: 72935.
  • 32
    Yamamoto H, Perez-Piteira J, Yoshida T, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999; 116: 134857.
  • 33
    Leung WK, Kim JJ, Kim JG, et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000; 156(2): 53743.
  • 34
    Leung SY, Yuen ST, Chung LP, et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 15964.
  • 35
    Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 284751.
  • 36
    Filipe MI, Osborn M, Linehan J, et al. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer 1995; 71: 306.
  • 37
    Yu J, Leung WK, Ng EKW, et al. Effect of H. pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia. Aliment Pharmacol Ther 2001; 15: 150512.
  • 38
    Morales TG, Sampliner RE, Camargo E. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J Clin Gastroenterol 2001; 32: 4004.DOI: 10.1097/00004836-200105000-00008
  • 39
    Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 37881.DOI: 10.1136/gut.50.3.378
  • 40
    Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 63942.
  • 41
    Van der Hulst RWM, Van Der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113: 2530.
  • 42
    Correa P, Fontham ETH, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter therapy. J Natl Cancer Inst 2000; 92: 18818.
  • 43
    Sung JJY, Lin SR, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 714.
  • 44
    Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 3806.
  • 45
    Blot WJ. Preventing cancer by disrupting progression of precancerous lesions. J Natl Cancer Inst 2000; 92: 18689.
  • 46
    Sung JJY, Lin SR, Leung WK, et al. Does eradication of H.pylori prevent deterioration of gastric atrophy and intestinal metaplasia? A 5-year follow-up. Gastroenterology 2002; 122: Abstract.
  • 47
    Zullo A, Rinaldi V, Hassan C, et al. Ascorbic acid and intestinal metaplasia in the stomach: a prospective randomized study. Aliment Pharmacol Ther 2000; 14: 13039.DOI: 10.1046/j.1365-2036.2000.00841.x
  • 48
    Langman MJ, Cheng KK, Gilman EA, et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br Med J 2000; 320: 16426.
  • 49
    Steinbach G, Lynch PM, Philips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 194652.
  • 50
    Nardone G, Staibano S, Rocco A, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogenic expression in patients with chronic gastritis. Gut 1999; 44: 78999.